Jean Emond, MD
Transplant Surgery · New York, NYNPI 1487606307
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Surgical Specialties Corporation (US), Inc. (dba Corza Medical) at 29.7% of the total.
Across 19 payments — averaging $91.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$517
- Fujifilm Healthcare Americas Corporation$285
- Intuitive Surgical$279
- Organox Ltd$172
- Johnson & Johnson$171
- Olympus America Inc.$154
- plus $162 from 5 others
What the payments were for
- Food & beverage$1,739100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 3 | $517 |
| Fujifilm Healthcare Americas Corporation | 2 | $285 |
| Intuitive Surgical | 3 | $279 |
| Organox Ltd | 1 | $172 |
| Johnson & Johnson | 3 | $171 |
| Olympus America Inc. | 2 | $154 |
| Regeneron | 1 | $77 |
| Mirum Pharmaceuticals, Inc. | 1 | $22 |
| Boston Scientific | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,739 in reported general payments places this provider in the 55th percentile of 72 transplant surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in New York
- Kishore IyerNew York$95K
- Jason HawksworthNew York$91K
- Parissa TabrizianNew York$74K
- Lloyd RatnerNew York$32K
- Hautien LiouNew York$31K
- Karim HalazunNew York$28K
- Myron SchwartzNew York$27K
- Ron ShapiroNew York$16K
- Gabriel GondolesiNew York$15K
- Lewis TepermanNew York$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.